NCT00941148 Beta-Cell Function of Insulin Glargine Compared to Neutral Protamine Hagedorn (NPH) Insuline and to Insulin Detemir in Combination With Metformin Status COMPLETED Phase PHASE4
NCT00935805 Glycemic And Blood Pressure Control In Type 2 Diabetes, In A Primary Care Unit: A Staged Management Strategy Status UNKNOWN Phase N/A
NCT00930579 Pre-Surgical Study: Effect of Metformin on Breast Cancer Proliferation Status COMPLETED Phase PHASE2
NCT00924573 Comparative Study of HOE490 O (Glimepiride and Metformin) Compared With Placebo on Top of Glimepiride Status COMPLETED Phase PHASE3
NCT00915772 Treatment of Type 2 Diabetes With Linagliptin 2.5 mg Bid + Metformin 500 or 1000 mg Bid and Metformin 1000 mg Bid Status COMPLETED Phase PHASE3
NCT00909506 Efficacy and Safety of Adjuvant Metformin for Operable Breast Cancer Patients Status COMPLETED Phase PHASE2
NCT00901979 A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM) Status COMPLETED Phase PHASE2
NCT00900146 Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients Status TERMINATED Phase PHASE2/PHASE3
NCT00897884 Clinical and Biologic Effects of Metformin in Early Stage Breast Cancer Status COMPLETED Phase NA
NCT00892073 Hypothalamic Obesity Following Craniopharyngioma Surgery: A Pilot Trial of Combined Metformin and Diazoxide Therapy Status COMPLETED Phase PHASE2
NCT00885352 Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128) Status COMPLETED Phase PHASE3
NCT00883259 Metformin and Gestational Diabetes in High-risk Patients: a RCTs Status UNKNOWN Phase PHASE4
NCT00881530 Empagliflozin (BI 10773) in Type Two Diabetes (T2D) Patients, Open Label Extension Status COMPLETED Phase PHASE2
NCT00871936 A Comparison of SLx-4090 in Combination With Metformin Versus Metformin Therapy Alone in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT00868790 A Study of the Safety and Efficacy of MK-3577 in Participants With Type 2 Diabetes Mellitus (MK-3577-009) Status TERMINATED Phase PHASE2
NCT00860288 Efficacy and Long-Term Safety of Vildagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE2/PHASE3
NCT00857870 Insulin Glargine First Line vs Metformin in Type 2 Diabetic Subjects Status COMPLETED Phase PHASE4
NCT00856986 The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00856284 Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3